EP Patent

EP4114388A1 — Methods of slowing brain volume loss

Assigned to Actelion Pharmaceuticals Ltd · Expires 2023-01-11 · 3y expired

What this patent protects

The disclosure relates to methods of slowing brain volume loss. In certain aspects, methods of slowing brain volume loss in a patient with multiple sclerosis are disclosed.

USPTO Abstract

The disclosure relates to methods of slowing brain volume loss. In certain aspects, methods of slowing brain volume loss in a patient with multiple sclerosis are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP4114388A1
Jurisdiction
EP
Classification
—
Expires
2023-01-11
Drug substance claim
No
Drug product claim
No
Assignee
Actelion Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.